Journal of Evidence-Based Dental Practice
Volume 4, Issue 3 , Pages 246-248 , September 2004

Saliva composition and flow rates are impacted by early HIV disease irrespective of xerostomic medications

REFERENCES 

  1. Atkinson JC, Yeh CK, Oppenheim FG, Bermudez D, Baum BJ, Fox PC. Elevation of salivary antimicrobial proteins following HIV-1 infection. J Aquir Immune Defic Syndr. 1990;3:41–48
  2. Coogan MM, Sweet SP, Challacombe SJ. Immunoglobulin A (IgA), IgA1 and IgA2 antibodies to Candida albicans in whole and parotid saliva in human immunodeficiency virus infection and AIDS. Infect Immun. 1994;62:892–896
  3. Navazesh M, Mulligan R, Komaroff E, Redford M, Greenspan D, Phelan J. The prevalence of xerostomia and salivary gland hypofunction in a cohort of HIV-positive and at-risk women. J Dent Res. 2000;79:1502–1507
  4. Lin AL, Johnson DA, Patterson TF, Wu Y, Lu D, Shi Q. Salivary anticandidal activity and saliva composition in an HIV-infected cohort. Oral Microbiol Immunol. 2001;16:270–278

PII: S1532-3382(04)00090-9

doi: 10.1016/j.jebdp.2004.07.001

Journal of Evidence-Based Dental Practice
Volume 4, Issue 3 , Pages 246-248 , September 2004

Article Tools